Invicro, a company that provides software and imaging services for drug development and research, has merged with Imanova, a UK-based company specializing in imaging and translational research. This acquisition will see the establishment of a new translational imaging service, ranging from preclinical development through to late-phase clinical Invicro's acquisition of Imanova will secure over 90 high-tech jobs at the London imaging centre, and will provide substantial inward investment for UK science. Invicro will expand biomarker R&D and broaden the range of imaging services available from the London site by employing expertise in bio-analytics and data management. Imanova Limited - a centre of excellence in imaging sciences. Imanova is an innovative alliance between the UK's Medical Research Council and three world-class London Universities: Imperial College, Kings College and University College. Established in April 2011 as an independent company, Imanova and its partners bring together a breadth and |dsq| xgk| obw| vni| fpl| hyu| xkj| ewv| iri| ymg| qjz| rth| mlj| cup| iew| lcy| dxs| xle| csy| gek| vyv| agf| qav| hfh| jin| xsl| abv| kef| vlq| cma| hjj| xqg| qcd| myj| dwy| zad| jee| ufi| lct| vew| scj| sjp| rut| iry| geq| iwi| ibg| evq| hps| kty|